160 related articles for article (PubMed ID: 37331004)
1. Transmorphic phage-guided systemic delivery of TNFα gene for the treatment of human pediatric medulloblastoma.
Al-Bahrani M; Asavarut P; Waramit S; Suwan K; Hajitou A
FASEB J; 2023 Jul; 37(7):e23038. PubMed ID: 37331004
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNFα) gene.
Chongchai A; Waramit S; Suwan K; Al-Bahrani M; Udomruk S; Phitak T; Kongtawelert P; Pothacharoen P; Hajitou A
FASEB J; 2021 May; 35(5):e21487. PubMed ID: 33811705
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors.
Tsafa E; Bentayebi K; Topanurak S; Yata T; Przystal J; Fongmoon D; Hajji N; Waramit S; Suwan K; Hajitou A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114050
[TBL] [Abstract][Full Text] [Related]
4. Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles.
Asavarut P; Waramit S; Suwan K; Marais GJK; Chongchai A; Benjathummarak S; Al-Bahrani M; Vila-Gomez P; Williams M; Kongtawelert P; Yata T; Hajitou A
EMBO Mol Med; 2022 Aug; 14(8):e15418. PubMed ID: 35758207
[TBL] [Abstract][Full Text] [Related]
5. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
[TBL] [Abstract][Full Text] [Related]
6. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
Hajitou A
Adv Genet; 2010; 69():65-82. PubMed ID: 20807602
[TBL] [Abstract][Full Text] [Related]
7. Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.
Tandle A; Hanna E; Lorang D; Hajitou A; Moya CA; Pasqualini R; Arap W; Adem A; Starker E; Hewitt S; Libutti SK
Cancer; 2009 Jan; 115(1):128-39. PubMed ID: 19090007
[TBL] [Abstract][Full Text] [Related]
8. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
[TBL] [Abstract][Full Text] [Related]
9. The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.
Tsafa E; Al-Bahrani M; Bentayebi K; Przystal J; Suwan K; Hajitou A
Oncotarget; 2016 Aug; 7(32):52135-52149. PubMed ID: 27437775
[TBL] [Abstract][Full Text] [Related]
10. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
[TBL] [Abstract][Full Text] [Related]
11. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo.
Al-Zoubi M; Salem AF; Martinez-Outschoorn UE; Whitaker-Menezes D; Lamb R; Hulit J; Howell A; Gandara R; Sartini M; Arafat H; Bevilacqua G; Sotgia F; Lisanti MP
Cell Cycle; 2013 Feb; 12(3):480-90. PubMed ID: 23292149
[TBL] [Abstract][Full Text] [Related]
12. TH1 predominance is associated with improved survival in pediatric medulloblastoma patients.
Wiegering V; Eyrich M; Rutkowski S; Wölfl M; Schlegel PG; Winkler B
Cancer Immunol Immunother; 2011 May; 60(5):693-703. PubMed ID: 21327638
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity.
Kircheis R; Ostermann E; Wolschek MF; Lichtenberger C; Magin-Lachmann C; Wightman L; Kursa M; Wagner E
Cancer Gene Ther; 2002 Aug; 9(8):673-80. PubMed ID: 12136428
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
15. Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.
Su B; Cengizeroglu A; Farkasova K; Viola JR; Anton M; Ellwart JW; Haase R; Wagner E; Ogris M
Mol Ther; 2013 Feb; 21(2):300-8. PubMed ID: 23299796
[TBL] [Abstract][Full Text] [Related]
16. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated transfer of the tumor necrosis factor alpha gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect.
Gillio Tos A; Cignetti A; Rovera G; Foa R
Blood; 1996 Mar; 87(6):2486-95. PubMed ID: 8630415
[TBL] [Abstract][Full Text] [Related]
18. Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors.
Yata T; Lee EL; Suwan K; Syed N; Asavarut P; Hajitou A
Mol Cancer; 2015 Jun; 14():110. PubMed ID: 26037383
[TBL] [Abstract][Full Text] [Related]
19. Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.
Nellan A; Rota C; Majzner R; Lester-McCully CM; Griesinger AM; Mulcahy Levy JM; Foreman NK; Warren KE; Lee DW
J Immunother Cancer; 2018 Apr; 6(1):30. PubMed ID: 29712574
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo.
Li Q; Li L; Shi W; Jiang X; Xu Y; Gong F; Zhou M; Edwards CK; Li Z
Cancer Immunol Immunother; 2006 Dec; 55(12):1470-9. PubMed ID: 16555058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
